'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Dyspareunia to Women's Health Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Dyspareunia to Women's Health Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Dyspareunia Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 65
Contact Us 66
Source 66
List of Tables
Dyspareunia Therapeutics, Global, Clinical Trials by Region, 2018* 7
Dyspareunia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Dyspareunia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Dyspareunia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Dyspareunia Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Dyspareunia Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Dyspareunia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Dyspareunia Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Dyspareunia to Women's Health Clinical Trials, G7 Countries (%), 2018* 16
Dyspareunia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Dyspareunia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Dyspareunia to Women's Health Clinical Trials, E7 Countries (%), 2018* 20
Dyspareunia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Dyspareunia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Dyspareunia Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Dyspareunia Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Dyspareunia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Dyspareunia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Dyspareunia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Dyspareunia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Dyspareunia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Dyspareunia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Dyspareunia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
List of Figures
Dyspareunia Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Dyspareunia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Dyspareunia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Dyspareunia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 11
Dyspareunia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Dyspareunia Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Dyspareunia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Dyspareunia to Women's Health Clinical Trials, G7 Countries (%), 2018* 16
Dyspareunia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Dyspareunia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Dyspareunia to Women's Health Clinical Trials, E7 Countries (%), 2018* 20
Dyspareunia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Dyspareunia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Dyspareunia Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Dyspareunia Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Dyspareunia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Dyspareunia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Dyspareunia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Dyspareunia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Dyspareunia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Dyspareunia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Dyspareunia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 65